Episode Details

Back to Episodes
two thousand twenty-six EHA | Phase III study of Tanxitumab combination therapy for newly

two thousand twenty-six EHA | Phase III study of Tanxitumab combination therapy for newly

Published 1 month ago
Description
Smf5Yv7iSAZW7lGwgunC
Listen Now

Love PodBriefly?

If you like Podbriefly.com, please consider donating to support the ongoing development.

Support Us